Tanya M Laidlaw Selected Research

Tanya M Laidlaw Research Topics

Disease

29	Asthma (Bronchial Asthma) 01/2022 - 07/2012
21	Nasal Polyps (Nasal Polyp) 01/2022 - 04/2012
15	Inflammation (Inflammations) 01/2021 - 01/2010
12	Rhinosinusitis 01/2022 - 03/2014
8	Eosinophilia 01/2022 - 10/2013
8	Hypersensitivity (Allergy) 01/2022 - 09/2008
4	Polyps 11/2019 - 10/2015
3	Rhinorrhea 09/2018 - 03/2014
3	Pneumonia (Pneumonitis) 10/2013 - 01/2010
2	Anosmia 05/2022 - 01/2022
2	Chronic Cough 05/2022 - 12/2021
2	Cough 05/2022 - 12/2021
2	Aspirin-Induced Asthma 01/2020 - 01/2019
2	Respiratory Sounds (Crackle) 09/2018 - 03/2014
2	Bronchial Spasm 09/2018 - 11/2016
2	Respiratory Hypersensitivity 01/2017 - 07/2012
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2015 - 07/2012
2	Vascular Remodeling 07/2012 - 01/2010
1	Chronic Urticaria 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Neurogenic Inflammation 12/2021
1	COVID-19 07/2021
1	Erythema 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Headache (Headaches) 01/2021
1	Hyperplasia 01/2021
1	Chronic Pain 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Nasopharyngitis 01/2021
1	Pain (Aches) 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Back Pain (Backache) 01/2021
1	Rhinitis 01/2021
1	Exanthema (Rash) 10/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Infections 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Lung Injury 01/2020
1	Bronchiectasis 01/2020
1	Asthma and Nasal Polyps 12/2019
1	Atopic Dermatitis (Atopic Eczema) 11/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Hypophosphatemia 01/2017
1	Muscle Cramp (Cramp) 01/2017
1	Chest Pain (Chest Pains) 11/2016
1	Nose Diseases (Disease, Nose) 11/2016
1	Coronary Vasospasm (Coronary Artery Vasospasm) 11/2016

Drug/Important Bio-Agent (IBA)

41	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 04/2012
8	Pharmaceutical PreparationsIBA 01/2022 - 05/2017
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 05/2017
6	dupilumabIBA 01/2022 - 09/2019
6	Cyclooxygenase 1IBA 01/2020 - 07/2016
5	CytokinesIBA 12/2021 - 07/2012
5	EnzymesIBA 01/2021 - 01/2010
4	Dinoprostone (PGE2)FDA Link 01/2022 - 07/2012
4	ProstaglandinsIBA 01/2019 - 01/2010
3	Immunoglobulin E (IgE)IBA 01/2021 - 07/2014
3	Biological ProductsIBA 01/2021 - 01/2020
3	LeukotrienesIBA 10/2020 - 10/2013
3	Leukotriene E4IBA 01/2019 - 12/2013
3	Leukotriene C4IBA 10/2015 - 12/2013
3	Prostaglandins EIBA 06/2014 - 01/2010
2	Interleukin-13IBA 01/2021 - 11/2019
2	Monoclonal AntibodiesIBA 01/2021 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2015
2	AllergensIBA 06/2015 - 01/2010
2	Thromboxane Receptors (Thromboxane Receptor)IBA 06/2015 - 07/2012
1	Antitussive Agents (Antitussives)FDA Link 05/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2022
1	Ion Channels (Ion Channel)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	mepolizumabIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	InterferonsIBA 01/2020
1	InterleukinsIBA 11/2019
1	DexpramipexoleIBA 01/2019
1	Cyclooxygenase InhibitorsIBA 01/2019
1	Investigational DrugsIBA 01/2019
1	GlucocorticoidsIBA 01/2017
1	Methacholine Chloride (Methacholine)FDA Link 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Tryptases (Tryptase)IBA 01/2017
1	Thymic Stromal LymphopoietinIBA 01/2016
1	Group V Phospholipases A2IBA 01/2016
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2016
1	Phospholipases A2 (Phospholipase A2)IBA 01/2016
1	CarboxypeptidasesIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016

Therapy/Procedure

9	Therapeutics 05/2022 - 07/2012
2	Drug Therapy (Chemotherapy) 05/2022 - 09/2008
1	Biological Therapy 01/2020
1	Drug Tapering 11/2016